MSX 2+
≈ 2 min read
Names in other languages
- EnglishMSX 2+
- gaMSX 2+
- glMSX 2+
- slMSX 2+
- СрпскиMSX 2+
- 日本語MSX2+
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
MSX-2 is a selective adenosine A 2A receptor antagonist used in scientific research. It is a xanthine and a derivative of the non-selective adenosine receptor antagonist caffeine. The affinities (K i ) of MSX-2 for the human adenosine receptors are 5.38 to 14.5 nM for the adenosine A 2A receptor, 2,500 nM for the adenosine A 1 receptor (172- to 465-fold lower than for the A 2A receptor), and >10,000 nM for the adenosine A 2B and A 3 receptors (>690-fold lower than for the A 2A receptor). MSX-2 has poor water solubility, which has limited the use of MSX-2 itself. Water-soluble ester prodrugs of MSX-2, including MSX-3 (a phosphate ester prodrug) and MSX-4 (an amino acid ester prodrug), have been developed and used in place of MSX-2. MSX-3 is best-suited for use by intravenous administration, whereas MSX-4 can be administered by oral administration. MSX-3 and MSX-4 reverse motivational deficits in animals and hence have the capacity to produce pro-motivational effects. MSX-2 and MSX-3 were first described in the scientific literature by 1998. Subsequently, MSX-4 was developed and described by 2008.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1328684014 under CC BY-SA 4.0; modifications have been made.
References
14 claims could not be tied to a specific sentence and are listed in the table below instead.